Cargando…
A Comprehensive Expression Analysis of Mucins in Appendiceal Carcinoma in a Multicenter Study: MUC3 Is a Novel Prognostic Factor
BACKGROUND: Mucins are implicated in survival in various cancers, but there have been no report addressed on survival in appendiceal carcinoma, an uncommon disease with different clinical and pathological features from those of other colon cancers. We aimed to investigate the clinical implications o...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4281150/ https://www.ncbi.nlm.nih.gov/pubmed/25551773 http://dx.doi.org/10.1371/journal.pone.0115613 |
_version_ | 1782350949263605760 |
---|---|
author | Shibahara, Hiroaki Higashi, Michiyo Yokoyama, Seiya Rousseau, Karine Kitazono, Iwao Osako, Masahiko Shirahama, Hiroshi Tashiro, Yukie Kurumiya, Yasuhiro Narita, Michihiko Kuze, Shingo Hasagawa, Hiroshi Kato, Takehito Kubota, Hitoshi Suzuki, Hideaki Arai, Toshiyuki Sakai, Yu Yuasa, Norihiro Fujino, Masahiko Kondo, Shinji Okamoto, Yoshichika Yamamoto, Tatsuyoshi Hiromatsu, Takashi Sasaki, Eiji Shirai, Kazuhisa Kawai, Satoru Hattori, Koutarou Tsuji, Hideki Okochi, Osamu Sakamoto, Masaki Kondo, Akinobu Konishi, Naomi Batra, Surinder K. Yonezawa, Suguru |
author_facet | Shibahara, Hiroaki Higashi, Michiyo Yokoyama, Seiya Rousseau, Karine Kitazono, Iwao Osako, Masahiko Shirahama, Hiroshi Tashiro, Yukie Kurumiya, Yasuhiro Narita, Michihiko Kuze, Shingo Hasagawa, Hiroshi Kato, Takehito Kubota, Hitoshi Suzuki, Hideaki Arai, Toshiyuki Sakai, Yu Yuasa, Norihiro Fujino, Masahiko Kondo, Shinji Okamoto, Yoshichika Yamamoto, Tatsuyoshi Hiromatsu, Takashi Sasaki, Eiji Shirai, Kazuhisa Kawai, Satoru Hattori, Koutarou Tsuji, Hideki Okochi, Osamu Sakamoto, Masaki Kondo, Akinobu Konishi, Naomi Batra, Surinder K. Yonezawa, Suguru |
author_sort | Shibahara, Hiroaki |
collection | PubMed |
description | BACKGROUND: Mucins are implicated in survival in various cancers, but there have been no report addressed on survival in appendiceal carcinoma, an uncommon disease with different clinical and pathological features from those of other colon cancers. We aimed to investigate the clinical implications of expression of mucins in appendiceal carcinoma. METHODS: Expression profiles of MUC1, MUC2, MUC3, MUC4, MUC5AC, MUC6, MUC16 and MUC17 in cancer tissue were examined by immunohistochemistry in 108 cases of surgically resected appendiceal carcinoma. RESULTS: The following relationships of mucins with clinicopathologic factors were identified: MUC1 with positive lymphatic invasion (p = 0.036); MUC2 with histological type (mucinous carcinoma, p<0.001), superficial invasion depth (p = 0.007), negative venous invasion (p = 0.003), and curative resection (p = 0.019); MUC3 with non-curative resection (p = 0.017); MUC5AC with histological type (mucinous carcinoma, p = 0.002), negative lymphatic invasion (p = 0.021), and negative venous invasion (p = 0.022); and MUC16 with positive lymph node metastasis (p = 0.035), positive venous invasion (p<0.05), and non-curative resection (p = 0.035). A poor prognosis was related to positive lymph node metastasis (p = 0.04), positive lymphatic invasion (p = 0.02), positive venous invasion (p<0.001), non-curative resection (p<0.001), and positive expression of MUC3 (p = 0.004). In multivariate analysis, positive venous invasion (HR: 6.93, 95% CI: 1.93–24.96, p = 0.003), non-curative resection (HR: 10.19, 95% CI: 3.05–34.07, p<0.001) and positive MUC3 expression (HR: 3.37, 95% CI: 1.13–10.03, p = 0.03) were identified as significant independent prognostic factors in patients with appendiceal carcinoma. CONCLUSIONS: Expression of MUC3 in appendiceal carcinoma is an independent factor for poor prognosis and a useful predictor of outcome in patients with appendiceal carcinoma after surgery. |
format | Online Article Text |
id | pubmed-4281150 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-42811502015-01-07 A Comprehensive Expression Analysis of Mucins in Appendiceal Carcinoma in a Multicenter Study: MUC3 Is a Novel Prognostic Factor Shibahara, Hiroaki Higashi, Michiyo Yokoyama, Seiya Rousseau, Karine Kitazono, Iwao Osako, Masahiko Shirahama, Hiroshi Tashiro, Yukie Kurumiya, Yasuhiro Narita, Michihiko Kuze, Shingo Hasagawa, Hiroshi Kato, Takehito Kubota, Hitoshi Suzuki, Hideaki Arai, Toshiyuki Sakai, Yu Yuasa, Norihiro Fujino, Masahiko Kondo, Shinji Okamoto, Yoshichika Yamamoto, Tatsuyoshi Hiromatsu, Takashi Sasaki, Eiji Shirai, Kazuhisa Kawai, Satoru Hattori, Koutarou Tsuji, Hideki Okochi, Osamu Sakamoto, Masaki Kondo, Akinobu Konishi, Naomi Batra, Surinder K. Yonezawa, Suguru PLoS One Research Article BACKGROUND: Mucins are implicated in survival in various cancers, but there have been no report addressed on survival in appendiceal carcinoma, an uncommon disease with different clinical and pathological features from those of other colon cancers. We aimed to investigate the clinical implications of expression of mucins in appendiceal carcinoma. METHODS: Expression profiles of MUC1, MUC2, MUC3, MUC4, MUC5AC, MUC6, MUC16 and MUC17 in cancer tissue were examined by immunohistochemistry in 108 cases of surgically resected appendiceal carcinoma. RESULTS: The following relationships of mucins with clinicopathologic factors were identified: MUC1 with positive lymphatic invasion (p = 0.036); MUC2 with histological type (mucinous carcinoma, p<0.001), superficial invasion depth (p = 0.007), negative venous invasion (p = 0.003), and curative resection (p = 0.019); MUC3 with non-curative resection (p = 0.017); MUC5AC with histological type (mucinous carcinoma, p = 0.002), negative lymphatic invasion (p = 0.021), and negative venous invasion (p = 0.022); and MUC16 with positive lymph node metastasis (p = 0.035), positive venous invasion (p<0.05), and non-curative resection (p = 0.035). A poor prognosis was related to positive lymph node metastasis (p = 0.04), positive lymphatic invasion (p = 0.02), positive venous invasion (p<0.001), non-curative resection (p<0.001), and positive expression of MUC3 (p = 0.004). In multivariate analysis, positive venous invasion (HR: 6.93, 95% CI: 1.93–24.96, p = 0.003), non-curative resection (HR: 10.19, 95% CI: 3.05–34.07, p<0.001) and positive MUC3 expression (HR: 3.37, 95% CI: 1.13–10.03, p = 0.03) were identified as significant independent prognostic factors in patients with appendiceal carcinoma. CONCLUSIONS: Expression of MUC3 in appendiceal carcinoma is an independent factor for poor prognosis and a useful predictor of outcome in patients with appendiceal carcinoma after surgery. Public Library of Science 2014-12-31 /pmc/articles/PMC4281150/ /pubmed/25551773 http://dx.doi.org/10.1371/journal.pone.0115613 Text en © 2014 Shibahara et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Shibahara, Hiroaki Higashi, Michiyo Yokoyama, Seiya Rousseau, Karine Kitazono, Iwao Osako, Masahiko Shirahama, Hiroshi Tashiro, Yukie Kurumiya, Yasuhiro Narita, Michihiko Kuze, Shingo Hasagawa, Hiroshi Kato, Takehito Kubota, Hitoshi Suzuki, Hideaki Arai, Toshiyuki Sakai, Yu Yuasa, Norihiro Fujino, Masahiko Kondo, Shinji Okamoto, Yoshichika Yamamoto, Tatsuyoshi Hiromatsu, Takashi Sasaki, Eiji Shirai, Kazuhisa Kawai, Satoru Hattori, Koutarou Tsuji, Hideki Okochi, Osamu Sakamoto, Masaki Kondo, Akinobu Konishi, Naomi Batra, Surinder K. Yonezawa, Suguru A Comprehensive Expression Analysis of Mucins in Appendiceal Carcinoma in a Multicenter Study: MUC3 Is a Novel Prognostic Factor |
title | A Comprehensive Expression Analysis of Mucins in Appendiceal Carcinoma in a Multicenter Study: MUC3 Is a Novel Prognostic Factor |
title_full | A Comprehensive Expression Analysis of Mucins in Appendiceal Carcinoma in a Multicenter Study: MUC3 Is a Novel Prognostic Factor |
title_fullStr | A Comprehensive Expression Analysis of Mucins in Appendiceal Carcinoma in a Multicenter Study: MUC3 Is a Novel Prognostic Factor |
title_full_unstemmed | A Comprehensive Expression Analysis of Mucins in Appendiceal Carcinoma in a Multicenter Study: MUC3 Is a Novel Prognostic Factor |
title_short | A Comprehensive Expression Analysis of Mucins in Appendiceal Carcinoma in a Multicenter Study: MUC3 Is a Novel Prognostic Factor |
title_sort | comprehensive expression analysis of mucins in appendiceal carcinoma in a multicenter study: muc3 is a novel prognostic factor |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4281150/ https://www.ncbi.nlm.nih.gov/pubmed/25551773 http://dx.doi.org/10.1371/journal.pone.0115613 |
work_keys_str_mv | AT shibaharahiroaki acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT higashimichiyo acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT yokoyamaseiya acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT rousseaukarine acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT kitazonoiwao acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT osakomasahiko acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT shirahamahiroshi acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT tashiroyukie acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT kurumiyayasuhiro acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT naritamichihiko acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT kuzeshingo acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT hasagawahiroshi acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT katotakehito acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT kubotahitoshi acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT suzukihideaki acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT araitoshiyuki acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT sakaiyu acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT yuasanorihiro acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT fujinomasahiko acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT kondoshinji acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT okamotoyoshichika acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT yamamototatsuyoshi acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT hiromatsutakashi acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT sasakieiji acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT shiraikazuhisa acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT kawaisatoru acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT hattorikoutarou acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT tsujihideki acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT okochiosamu acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT sakamotomasaki acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT kondoakinobu acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT konishinaomi acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT batrasurinderk acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT yonezawasuguru acomprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT shibaharahiroaki comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT higashimichiyo comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT yokoyamaseiya comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT rousseaukarine comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT kitazonoiwao comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT osakomasahiko comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT shirahamahiroshi comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT tashiroyukie comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT kurumiyayasuhiro comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT naritamichihiko comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT kuzeshingo comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT hasagawahiroshi comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT katotakehito comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT kubotahitoshi comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT suzukihideaki comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT araitoshiyuki comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT sakaiyu comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT yuasanorihiro comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT fujinomasahiko comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT kondoshinji comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT okamotoyoshichika comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT yamamototatsuyoshi comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT hiromatsutakashi comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT sasakieiji comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT shiraikazuhisa comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT kawaisatoru comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT hattorikoutarou comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT tsujihideki comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT okochiosamu comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT sakamotomasaki comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT kondoakinobu comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT konishinaomi comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT batrasurinderk comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor AT yonezawasuguru comprehensiveexpressionanalysisofmucinsinappendicealcarcinomainamulticenterstudymuc3isanovelprognosticfactor |